Home > PE Ratio > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of FREDUN PHARMACEUTICALS is 33.94.

Share Price ₹2,311.3Jun 09,2026
Market Cap ₹1,271.2 Cr
Earnings-TTM₹37.5 CrTTM-Consolidated Results
Price/Earnings33.94xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of FREDUN PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of FREDUN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,271.2 Cr] as on Jun 09,2026

(/) Earnings [ ₹37.5 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 33.94x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for FREDUN PHARMACEUTICALS , the investors are currently willing to pay 33.94 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FREDUN PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of FREDUN PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of FREDUN PHARMACEUTICALS


PE Ratio Performance Analysis for FREDUN PHARMACEUTICALS

- FREDUN PHARMACEUTICALS 's latest p/e ratio is 33.94x.

- FREDUN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2025 averaged 22.02x.

- FREDUN PHARMACEUTICALS 's operated at median p/e ratio of 28.05x from fiscal years ending March 2018 to 2022.

- Looking back at the last 2 fiscal years, FREDUN PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 28.05x.

- FREDUN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2025 of 15.99x.


How does FREDUN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
FREDUN PHARMACEUTICALS 37.4533.941,271.2
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5036.92426,938.0
DIVIS LABORATORIES LTD2,568.0069.84179,361.0
TORRENT PHARMACEUTICALS LTD2,138.0070.81151,385.0
CIPLA LTD3,869.7928.74111,220.0
DR REDDYS LABORATORIES LTD4,144.2025.55105,899.0
MANKIND PHARMA LTD1,926.4151.2698,745.3
LUPIN LTD5,355.4719.32103,490.0
ZYDUS LIFESCIENCES LTD5,026.4022.14111,264.0
AUROBINDO PHARMA LTD3,501.4523.7683,208.3
LAURUS LABS LTD889.8586.4876,955.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FREDUN PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.32x
Max industry PE 86.48x
Median industry PE 33.94x
Average industry PE 42.62x



You may also like the below Video Courses